Patient and caregiver outcomes after 6±1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease : The Belgian FExT study

• METS T

収録刊行物

• Curr Med Res Opin

  Curr Med Res Opin 23 2485-2501, 2007

詳細情報

• CRID: 1573950400965939456
• NII論文ID: 10027275193
• データソース種別:
  • CiNii Articles